| Drug Type Enzyme | 
| Synonyms ARSBM6P, M 201, M201 | 
| Target | 
| Action modulators | 
| Mechanism ASB modulators(arylsulfatase B modulators) | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhasePreclinical | 
| First Approval Date- | 
| Regulation- | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Mucopolysaccharidosis VI | Preclinical | United States  | 01 Nov 2024 | 






